Onderneming Genix Pharmaceuticals Corporation Toronto S.E.
Aandelen
GENX
CA0209261019
Voedselverwerking
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,17 CAD | -.--% |
|
-.--% | -.--% |
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Nutraceutical and Pharmaceutical Products
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | nan % | 0 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11-03-19 |
Mahmoud Aziz
CHM | Chairman | - | 19-05-21 |
Danny Lee
DFI | Director of Finance/CFO | - | 14-12-20 |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05-09-19 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11-03-19 |
Buckley Dodds
AUD | Comptroller/Controller/Auditor | - | 26-05-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Danny Lee
DFI | Director of Finance/CFO | - | 14-12-20 |
Jamie Lewin
BRD | Director/Board Member | 74 | 11-03-19 |
Mahmoud Aziz
CHM | Chairman | - | 19-05-21 |
Paul Chow
BRD | Director/Board Member | 59 | - |
Kevin Bottomley
BRD | Director/Board Member | 45 | 05-09-19 |
Sina Pirooz
CEO | Chief Executive Officer | 55 | 11-03-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 59 224 131 | 33 550 348 ( 56,65 %) | 0 | 56,65 % |
Bedrijfsgegevens
Genix Pharmaceuticals Corp.
1055 West Hastings Street Suite 300
V6E 2E9, Vancouver
+604-609-6198
http://www.genixpharm.com![Adres Genix Pharmaceuticals Corporation(GENX)](https://cdn.zonebourse.com/static/address/60342547.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,27% | 8,27 mld. | |
+3,37% | 7,47 mld. | |
-11,26% | 5,23 mld. | |
-8,69% | 3,62 mld. | |
-18,20% | 3,26 mld. | |
-11,27% | 1,22 mld. | |
-30,34% | 1,06 mld. | |
-10,34% | 861 mln. | |
-16,06% | 857 mln. |
- Beurs
- Aandelen
- Koers GENX
- Koers GENX
- Onderneming Genix Pharmaceuticals Corporation